The Problem
Vascular access in intensive care comes with high stakes: critical patients, limited attempts, costly procedures, and pressure on bed availability.
Install-Vasc addresses these challenges with enhanced vessel targeting, assisted rotation, precise needle advancement, and one-handed control — designed to improve efficiency and success at the bedside.
Current ultrasound systems offer limited support for accurate needle placement.
Amount of Catheters Inserted Per Year
300M
United States
2B
Worldwide
Failure Rate of Catheters Insertion
28 % - 55 %
Worldwide
Annual Staff Cost per Failure
$13.3K
United States
Install-Vasc is our medical device that attaches to most ultrasound machines. It helps healthcare professionals insert catheters safely by guiding the needle with precision. Thanks to its built-in rotation and alignment system (ANTT), Install-Vasc makes ultrasound-guided procedures easier, faster, and more secure for both patients and clinicians.
Our Solution
OPERATIONAL EFFICIENCY & COST SAVINGS
-
Reduces complications and costs related to catheter insertion, helping streamline care delivery.
INCREASED PRODUCTIVITY
-
Accelerates catheter insertion procedures, enabling faster patient treatment and improved workflow.
ENHANCED PROFITABILITY
-
Optimizes hospital resources by reducing procedure-related complications and supporting smarter budget allocation.
Literature Review of Peripheral Vascular Access (Install-Vasc)
Introduction
Peripheral intravenous catheters (PIVCs) are the workhorse of modern intravenous therapy. Placement of a PIVC is the most common invasive hospital procedure, with more than 300 million catheters inserted each year in the United States and about two billion PIVCs used globally every year (Zhang, 2022). Because most hospitalized patients require intravenous access, PIVC insertion has become routine; 60–90 % of patients will need some form of vascular access device during their hospital stay (Zhang, 2022). PIVCs are intended for short-term use (< 1 week), yet they are often removed prematurely because of mechanical complications or infection. The high utilisation rate of these devices, combined with their non-trivial complication profile, drives both clinical research (e.g., innovations in devices and insertion techniques) and a large commercial market for catheters and associated supplies.
See more: